CVRx, Inc. (CVRX) has 20 bekannte Insider- und institutionelle Anteilseigner verzeichnet. Der größte Anteilseigner ist JOHNSON & JOHNSON mit 4,031,198 Aktien. Weitere bedeutende Anteilseigner sind Johnson & Johnson Innovation - JJDC, Inc. und Jain Mudit K..
In den letzten 12 Monaten haben Insider 38 Transaktionen in CVRX Aktien getätigt — 23 Käufe (im Wert von $5.97M) und 13 Verkäufe (im Wert von $987.62K). Insider-Käufe haben die Verkäufe übertroffen, was auf Vertrauen in die Unternehmensaussichten hindeuten kann.
CVRX Insider-Beteiligungen
Größter Aktionär
JOHNSON & JOHNSON
4,031,198 Aktien
Käufe (12 Monate)
23
$5.97M Wert
Verkäufe (12 Monate)
13
$987.62K Wert
12-Monats-Transaktionsaktivität
Top-Insider-Aktionäre
| # |
Name |
Funktion |
Gehaltene Aktien |
Zuletzt gemeldet |
Relative Größe |
| 1 |
Johnson & Johnson |
10 Percent Owner |
4,031,198 |
2026-01-08 |
|
| 2 |
Johnson & Johnson Innovation - Jjdc, Inc. |
10 Percent Owner |
3,495,575 |
2023-09-18 |
|
| 3 |
Jain Mudit K. |
Director |
980,183 |
2026-02-23 |
|
| 4 |
Hykes Kevin |
Pres & CEO |
238,000 |
2026-03-03 |
|
| 5 |
Oasheim Jared |
Chief Financial Officer |
91,000 |
2026-03-03 |
|
| 6 |
Adamson Philip B. |
Chief Medical Officer |
62,000 |
2026-03-16 |
|
| 7 |
Verrastro Paul |
Chief Mktg & Strat Officer |
61,835 |
2026-03-03 |
|
| 8 |
John Robert Allen |
Chief Revenue Officer |
52,000 |
2026-03-03 |
|
| 9 |
Morrison Gregory |
Chief Human Resources Officer |
34,000 |
2026-03-04 |
|
| 10 |
Palmer Craig E. |
SVP, U.s. Sales |
31,600 |
2024-02-06 |
|
| 11 |
Behbahani Ali |
Director |
27,250 |
2024-06-07 |
|
| 12 |
Nehra John M |
Director |
26,985 |
2022-06-09 |
|
| 13 |
Galle Liz |
VP of Global Clinical Research |
26,000 |
2023-01-20 |
|
| 14 |
Binkowski Brent |
Chief Operating Officer |
23,000 |
2026-03-03 |
|
| 15 |
Yared Nadim |
Chief Executive Officer |
22,050 |
2024-02-06 |
|
| 16 |
Hill, Mitch C. |
Director |
19,554 |
2025-06-05 |
|
| 17 |
Nielsen Kirk G. |
Director |
19,554 |
2025-06-05 |
|
| 18 |
Slattery Joseph P |
Director |
19,554 |
2025-06-05 |
|
| 19 |
Ballinger Kevin J. |
Director |
19,554 |
2025-06-05 |
|
| 20 |
Shadan Martha |
Director |
19,554 |
2025-06-05 |
|
Aktuelle Transaktionen (letzte 12 Monate)
| Datum |
Name |
Funktion |
Typ |
Aktien |
Kurs |
Wert |
| 2026-03-02 |
Adamson Philip B. |
Chief Medical Officer |
Informierter Verkauf |
1,262 |
$7.90 |
$9.97K |
| 2026-02-27 |
Adamson Philip B. |
Chief Medical Officer |
RSU-Zuteilung |
62,000 |
$8.16 |
$505.92K |
| 2026-03-02 |
Morrison Gregory |
Chief Human Resources Officer |
RSU-Zuteilung |
34,000 |
- |
- |
| 2026-03-02 |
Morrison Gregory |
Officer |
Unbekannt |
- |
- |
- |
| 2026-03-02 |
John Robert Allen |
Chief Revenue Officer |
Informierter Verkauf |
3,964 |
$7.90 |
$31.33K |
| 2026-02-27 |
John Robert Allen |
Chief Revenue Officer |
RSU-Zuteilung |
52,000 |
$8.16 |
$424.32K |
| 2026-03-02 |
Verrastro Paul |
Chief Mktg & Strat Officer |
Informierter Verkauf |
1,284 |
$7.90 |
$10.15K |
| 2026-02-27 |
Verrastro Paul |
Chief Mktg & Strat Officer |
RSU-Zuteilung |
45,000 |
- |
- |
| 2026-03-02 |
Oasheim Jared |
Chief Financial Officer |
Informierter Verkauf |
1,744 |
$7.90 |
$13.78K |
| 2026-02-27 |
Oasheim Jared |
Chief Financial Officer |
RSU-Zuteilung |
91,000 |
$8.16 |
$742.56K |
| 2026-02-27 |
Binkowski Brent |
Chief Operating Officer |
RSU-Zuteilung |
23,000 |
$8.16 |
$187.68K |
| 2026-03-02 |
Hykes Kevin |
Pres & CEO |
Informierter Verkauf |
7,763 |
$7.90 |
$61.35K |
| 2026-02-27 |
Hykes Kevin |
Pres & CEO |
RSU-Zuteilung |
238,000 |
$8.16 |
$1.94M |
| 2026-02-20 |
Jain Mudit K. |
Director |
Informierter Kauf |
46,800 |
$6.36 |
$297.59K |
| 2026-02-18 |
Jain Mudit K. |
Director |
Informierter Kauf |
600 |
$4.64 |
$2.79K |
| 2025-11-26 |
Johnson & Johnson |
10 Percent Owner |
Informierter Verkauf |
6,337 |
$10.03 |
$63.56K |
| 2025-11-25 |
Johnson & Johnson |
10 Percent Owner |
Informierter Verkauf |
16,000 |
$10.03 |
$160.48K |
| 2025-11-26 |
Johnson & Johnson |
10 Percent Owner |
Informierter Verkauf |
6,337 |
$10.03 |
$63.56K |
| 2025-11-24 |
Johnson & Johnson |
10 Percent Owner |
Informierter Verkauf |
2,200 |
$10.06 |
$22.13K |
| 2025-11-21 |
Johnson & Johnson |
10 Percent Owner |
Informierter Verkauf |
500 |
$10.00 |
$5K |
| 2025-11-12 |
Johnson & Johnson |
10 Percent Owner |
Informierter Verkauf |
1,000 |
$10.00 |
$10K |
| 2025-11-07 |
Johnson & Johnson |
10 Percent Owner |
Informierter Verkauf |
200 |
$10.00 |
$2K |
| 2025-11-06 |
Johnson & Johnson |
10 Percent Owner |
Informierter Verkauf |
52,332 |
$10.21 |
$534.31K |
| 2025-08-11 |
Binkowski Brent |
Chief Operating Officer |
RSU-Zuteilung |
16,600 |
- |
- |
| 2025-08-11 |
Binkowski Brent |
Officer |
Unbekannt |
- |
- |
- |
